Fmr LLC Has $110.88 Million Stock Holdings in agilon health, inc. (NYSE:AGL)

FMR LLC lowered its holdings in agilon health, inc. (NYSE:AGL - Free Report) by 50.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 28,214,252 shares of the company's stock after selling 28,712,991 shares during the quarter. FMR LLC owned about 6.85% of agilon health worth $110,882,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd acquired a new position in shares of agilon health during the third quarter valued at $171,000. Algert Global LLC raised its holdings in agilon health by 80.2% during the 3rd quarter. Algert Global LLC now owns 184,530 shares of the company's stock worth $725,000 after purchasing an additional 82,123 shares during the last quarter. Citigroup Inc. lifted its position in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period. Intech Investment Management LLC bought a new position in shares of agilon health in the 3rd quarter valued at about $228,000. Finally, Simplify Asset Management Inc. grew its position in shares of agilon health by 67.5% during the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company's stock worth $663,000 after buying an additional 67,968 shares during the period.

Wall Street Analyst Weigh In

A number of analysts have commented on AGL shares. JMP Securities lowered shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Stifel Nicolaus cut their target price on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research note on Tuesday, November 12th. William Blair cut agilon health from an "outperform" rating to a "market perform" rating in a report on Friday, November 8th. Bank of America cut shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Finally, Benchmark restated a "buy" rating and set a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, agilon health has an average rating of "Hold" and a consensus price target of $6.05.

Insiders Place Their Bets

In other agilon health news, CEO Steven Sell bought 20,000 shares of the stock in a transaction on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 3.20% of the company's stock.

agilon health Stock Performance

NYSE AGL traded down $0.02 on Thursday, reaching $2.21. The stock had a trading volume of 3,289,557 shares, compared to its average volume of 4,899,222. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $13.76. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market cap of $910.56 million, a P/E ratio of -2.35 and a beta of 0.51. The firm has a fifty day moving average of $2.63 and a two-hundred day moving average of $4.56.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the firm earned ($0.06) EPS. On average, equities research analysts anticipate that agilon health, inc. will post -0.47 EPS for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.